alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

Term ID

CHEBI:140717

Synonyms

globoside MSGG (d18:0)
Monosialyl-Gb5Cer(d18:0)
MSGG(d18:0)
N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine
SSEA-4(d18:0)

(all 5)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: Monosialyl-Gb5(1-) organic molecular entity

Monosialyl-Gb5(1-) organic molecular entity Show first 5 Terms
has_functional_parent: beta-D-Gal-(1->3)- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)- beta-D-Glc-(1<->1')-Cer(d18:0)

beta-D-Gal-(1->3)- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)- beta-D-Glc-(1<->1')-Cer(d18:0) Show first 5 Terms
inverse has_functional_parent: alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuAc-(2->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine alpha-NeuAc-(2->6)-(alpha-NeuAc-(2->3))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuAc-(2->6)]-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine alpha-NeuAc-(2->6)-(alpha-NeuAc-(2->3))-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine alpha-NeuAc-(2->8)-alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine Show first 5 Terms

Phenotype

Phenotype resulting from alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

Phenotype where environments contain alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

Phenotype modified by environments containing alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

Phenotype affecting alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-N-acylsphinganine

Human Disease Model